Metabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkers.

It is important to identify patients with Maturity-onset diabetes of the young (MODY) as a molecular diagnosis determines both treatment and prognosis. Genetic testing is currently expensive and many patients are therefore not assessed and are misclassified as having either type 1 or type 2 diabetes...

詳細記述

書誌詳細
主要な著者: Gloyn, A, Faber, J, Malmodin, D, Thanabalasingham, G, Lam, F, Ueland, P, McCarthy, M, Owen, K, Baunsgaard, D
フォーマット: Journal article
言語:English
出版事項: Public Library of Science 2012

類似資料